🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 3 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 25/08/2025 | 310,72 | 312,65 | 304,84 | 305,38 | -2,19% | 2,51% | 659.900 |
| 22/08/2025 | 310,00 | 315,73 | 308,26 | 312,23 | +0,51% | 2,41% | 576.500 |
| 21/08/2025 | 303,59 | 311,37 | 303,59 | 310,66 | +1,36% | 2,56% | 546.900 |
| 20/08/2025 | 313,22 | 314,98 | 306,01 | 306,48 | -2,15% | 2,86% | 685.000 |
| 19/08/2025 | 314,10 | 317,31 | 311,36 | 313,22 | -0,28% | 1,89% | 595.000 |
| 18/08/2025 | 314,03 | 316,21 | 311,55 | 314,10 | +0,31% | 1,48% | 651.700 |
| 15/08/2025 | 312,13 | 314,24 | 310,61 | 313,13 | +0,34% | 1,16% | 703.800 |
| 14/08/2025 | 308,83 | 312,48 | 305,00 | 312,06 | +0,76% | 2,42% | 587.000 |
| 13/08/2025 | 302,96 | 310,07 | 301,30 | 309,72 | +2,76% | 2,89% | 579.500 |
| 12/08/2025 | 298,76 | 302,68 | 292,34 | 301,39 | +0,32% | 3,46% | 883.700 |
| 11/08/2025 | 301,97 | 306,00 | 300,24 | 300,43 | -0,35% | 1,91% | 629.900 |
| 08/08/2025 | 297,38 | 305,36 | 297,38 | 301,50 | +0,69% | 2,68% | 579.900 |
| 07/08/2025 | 302,22 | 304,77 | 296,57 | 299,42 | -0,99% | 2,71% | 572.300 |
| 06/08/2025 | 301,85 | 307,06 | 299,45 | 302,41 | -0,79% | 2,52% | 540.900 |
| 05/08/2025 | 292,02 | 307,49 | 291,22 | 304,81 | +4,16% | 5,57% | 1.142.300 |
| 04/08/2025 | 291,85 | 294,34 | 287,65 | 292,65 | -0,55% | 2,29% | 909.300 |
| 01/08/2025 | 284,65 | 296,60 | 283,01 | 294,28 | +7,13% | 4,77% | 2.428.900 |
| 31/07/2025 | 283,25 | 284,00 | 272,12 | 274,70 | -2,57% | 4,19% | 641.000 |
| 30/07/2025 | 285,59 | 300,49 | 280,35 | 281,95 | -5,25% | 7,05% | 1.021.000 |
| 29/07/2025 | 299,19 | 302,14 | 296,85 | 297,56 | -0,19% | 1,77% | 527.100 |
| 28/07/2025 | 304,75 | 306,24 | 297,30 | 298,14 | -2,09% | 2,93% | 497.300 |
| 25/07/2025 | 306,80 | 307,27 | 302,11 | 304,50 | -0,62% | 1,68% | 310.900 |
| 24/07/2025 | 305,87 | 307,71 | 302,65 | 306,41 | +0,26% | 1,65% | 403.400 |
| 23/07/2025 | 300,69 | 306,92 | 299,02 | 305,61 | +2,59% | 2,63% | 431.100 |
| 22/07/2025 | 293,99 | 298,91 | 293,99 | 297,89 | +1,63% | 1,67% | 372.400 |
| 21/07/2025 | 292,01 | 296,56 | 291,47 | 293,12 | +0,38% | 1,74% | 279.800 |
| 18/07/2025 | 298,31 | 299,15 | 290,80 | 292,01 | -1,79% | 2,80% | 322.700 |
| 17/07/2025 | 296,80 | 302,52 | 293,66 | 297,33 | -0,28% | 2,99% | 459.500 |
| 16/07/2025 | 295,25 | 299,83 | 295,01 | 298,16 | +1,68% | 1,63% | 324.800 |
| 15/07/2025 | 297,70 | 300,37 | 291,72 | 293,24 | -1,49% | 2,91% | 303.200 |